Immunai, an AI biotech company specializing in mapping the human immune system, and the Parker Institute for Cancer Immunotherapy (PICI), a San Francisco-based nonprofit organization that unites ...
10d
LOTTE Holdings Healthcare and Biopharmaceutical CVC Announces Investment in OmicInsight Corporation
TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in OmicInsight Corporation ...
Comparing impact of treatment before or after surgery in patients with stage II-IIIb resectable non-small cell lung cancer (NSCLC; Alliance A082304-SWOG S2402). This is an ASCO Meeting Abstract from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results